MAGNORA And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – MAGNORA (MGN.OL), NAVAMEDIC (NAVA.OL), MELHUS SPAREBANK (MELG.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. MAGNORA (MGN.OL)

210.1% sales growth and 52.28% return on equity

Magnora ASA operates as a renewable energy development company. It primarily focuses on developing wind and solar photovoltaic (PV) projects. The company also hold license agreements with the Dana Western Isles and Shell Penguins FPSO. It serves oil companies and marine contractors in the United Kingdom, Norway, and Sweden. The company was formerly known as Sevan Marine ASA and changed its name to Magnora ASA in October 2018. Magnora ASA was incorporated in 2001 and is based in Oslo, Norway.

Earnings Per Share

As for profitability, MAGNORA has a trailing twelve months EPS of kr3.95.

PE Ratio

MAGNORA has a trailing twelve months price to earnings ratio of 7.58. Meaning, the purchaser of the share is investing kr7.58 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 52.28%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

MAGNORA’s EBITDA is -76.25.

Sales Growth

MAGNORA’s sales growth is negative 94.8% for the present quarter and 210.1% for the next.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is 85.7% and a drop 11.5% for the next.

Moving Average

MAGNORA’s worth is under its 50-day moving average of kr31.36 and below its 200-day moving average of kr30.46.

More news about MAGNORA.

2. NAVAMEDIC (NAVA.OL)

20.7% sales growth and 11.97% return on equity

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.

PE Ratio

NAVAMEDIC has a trailing twelve months price to earnings ratio of 33.14. Meaning, the purchaser of the share is investing kr33.14 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.97%.

More news about NAVAMEDIC.

3. MELHUS SPAREBANK (MELG.OL)

15.6% sales growth and 10.56% return on equity

Melhus Sparebank, a savings bank, provides various banking products and services to companies, agriculture customers, and private individuals in Norway. The company offers savings accounts; construction and business loans; mortgage, and car loans; bank guarantee, overdraft, and leasing services; and credit and bank cards. It also provides various insurance products for home, cottage, household goods, contents, drone, car, boat, other vehicles, travel, animal, children, death, health, critical illness, disabled, private, commercial, agricultural, and accident; savings and pension products; payment services; and online and mobile banking services. The company operates through branch offices in central Trondheim, Heimdal, Ler, and Korsvegen. Melhus Sparebank was founded in 1840 and is headquartered in Melhus, Norway.

Earnings Per Share

As for profitability, MELHUS SPAREBANK has a trailing twelve months EPS of kr17.12.

PE Ratio

MELHUS SPAREBANK has a trailing twelve months price to earnings ratio of 9.46. Meaning, the purchaser of the share is investing kr9.46 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.56%.

More news about MELHUS SPAREBANK.

4. ODFJELL TECHNOLOGY (OTL.OL)

12.4% sales growth and 34.07% return on equity

Odfjell Technology Ltd., a technology and engineering company, provides well, drilling, and engineering services in Norway, Europe, Asia, the United Kingdom, and internationally. The company operates through three segments: Well Services; Operations; and Projects & Engineering. The Well Services segment provides casing and tubular running services, including automated and conventional; drilling tool and tubular rental services; and specialist well intervention products and services for exploration wells and for production. The Operations segment engages in the production of drilling and well completion on client's rigs. This segment is also involved in the slot recovery, plug and abandonment, work-overs, and maintenance activities; and provision of platform drilling services on both fixed production platforms and on floating production platforms with subsea blowout preventers along with the management and performance of the services on leased Jack-up rigs. The Projects & Engineering segment offers engineering and integrity services, including design and engineering to building supervision; and project management and operational support for units in operation, newbuild projects, and SPS/RS recertification projects and yard stays. The company was founded in 1973 and is headquartered in Aberdeen, the United Kingdom.

Earnings Per Share

As for profitability, ODFJELL TECHNOLOGY has a trailing twelve months EPS of kr7.92.

PE Ratio

ODFJELL TECHNOLOGY has a trailing twelve months price to earnings ratio of 7.4. Meaning, the purchaser of the share is investing kr7.4 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.07%.

Sales Growth

ODFJELL TECHNOLOGY’s sales growth is 14% for the present quarter and 12.4% for the next.

Moving Average

ODFJELL TECHNOLOGY’s worth is higher than its 50-day moving average of kr53.50 and way higher than its 200-day moving average of kr51.24.

Revenue Growth

Year-on-year quarterly revenue growth grew by 28.1%, now sitting on 4.81B for the twelve trailing months.

More news about ODFJELL TECHNOLOGY.

Leave a Reply

Your email address will not be published. Required fields are marked *